CVM
LSTA icon

Cheviot Value Management’s Lisata Therapeutics LSTA Stock Holding History

Cheviot Value Management’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10 Hold
3
– – ﹤0.01% 441
2026
Q1 		$15 Hold
3
– – ﹤0.01% 423
2025
Q4 		$14 Hold
3
– – ﹤0.01% 414
2025
Q3 		$8 Hold
3
– – ﹤0.01% 442
2025
Q2 		$8 Hold
3
– – ﹤0.01% 431
2025
Q1 		$7 Buy
+3
New +$8 ﹤0.01% 453

Other funds holding LSTA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

Cheviot Value Management's LSTA Position: Q2 2026 in Review

Cheviot Value Management held its Lisata Therapeutics (LSTA) position steady in Q2 2026 at 3 shares worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #441.

Cheviot Value Management first reported a position in LSTA in Q1 2025 and has held it in 6 quarters since. The position peaked at $15 in Q1 2026. 31 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.

  • Cheviot Value Management held 3 shares of Lisata Therapeutics worth $10 as of Q2 2026.
  • Cheviot Value Management left its Lisata Therapeutics share count unchanged in Q2 2026.
  • Lisata Therapeutics made up ﹤0.01% of Cheviot Value Management's portfolio in Q2 2026, its #441 holding.
  • Cheviot Value Management first reported a position in Lisata Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Cheviot Value Management's Lisata Therapeutics position peaked at $15 in Q1 2026.
  • 31 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.

Based on Cheviot Value Management's 13F filing for Q2 2026, filed 6 Aug 2026.